Platelet-rich plasma in the treatment of Rotator Cuff tears: a randomized, double-blinded, controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900028555

Enrollment

Unknown

Registered

2019-12-27

Start date

2020-01-01

Completion date

Unknown

Last updated

2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rotator Cuff Tears

Interventions

Experimental group:PRP

Control group:0.9%N.S.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosis of rotartor cuff tears by medical history, physical examination and imaging examination; 2. Aged 18-70 years

Exclusion criteria

Exclusion criteria: 1. The shoulder has been operated; 2. Other diseases of the shoulder joint; for example, tumors, autoimmune diseases.

Design outcomes

Primary

Measure	Time frame
UCLA scores;	—

Countries

China

Contacts

Public ContactLIU YAN

West China Hospital, Sichuan University

123315971@qq.com+86 18190030357

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026